A new in vitro model to study endothelial injury

Area of Science:

• Endothelial biology
• Vascular research
• Immunology

Background:

• Endothelial dysfunction, or endothelialitis, is a key feature in diseases like atherosclerosis and transplant rejection.
• Drugs such as cyclosporin A (CyA) induce endothelial dysfunction, leading to allograft vasculopathy and graft loss.
• A need exists for an in vitro model to study the morphological effects of endothelial injury and dysfunction.

Purpose of the Study:

• To develop and validate a novel in vitro morphological assay for studying endothelial dysfunction.
• To investigate the effects of cyclosporin A (CyA) on endothelial cell capillary tube formation.
• To assess the assay's ability to differentiate varying degrees of endothelial dysfunction.

Main Methods:

• Utilized a model of mouse endothelial cells (SVEC 4-10) cultured on Matrigel to form capillary tubes.
• Studied the effects of varying doses of CyA on capillary tube initiation and disruption.
• Adapted the assay to a 96-well plate format for high-throughput screening, using IFN-gamma as a positive control.

Main Results:

• The assay successfully adapted to a 96-well format.
• Cyclosporin A induced endothelial dysfunction, inhibiting tube formation and disrupting mature tubes at higher doses (2-20 microg/ml).
• Lower CyA doses inhibited initiation only, while IL-2 and IFN-gamma inhibited initiation but not disruption; cell viability remained unaffected.

Conclusions:

• A novel in vitro morphological assay for capillary tube formation effectively models CyA-induced endothelial dysfunction.
• The assay can distinguish between mild and severe endothelial dysfunction.
• This model provides a tool for studying allograft vasculopathy and other forms of vasculitis.